Business and regulatory insight for orthotics, prosthetics, foot health and rehabilitation markets worldwide, from the Deliberate team and our publications IMEA CPO and Bharat CPO.
- Beyond the Brochure: O&P Marketing in IMEA Starts with Clarity
The biggest constraint on many O&P businesses is not budget but focus. Before choosing channels, organisations need to be clear on who they serve and why referrers should trust them. - Embla Medical’s Q3: Why Regional Demand Matters More Than Headline Growth
Embla Medical grew 4% organically in Q3 2026, led by EMEA and Prosthetics & Neuro Orthotics, while the Americas were flat and APAC declined. The mix holds lessons for market prioritisation. - India’s Supreme Court Reframes Prosthetic Compensation: A Market Signal for Manufacturers
A Supreme Court ruling treats a prosthesis as a lifelong, clinically appropriate need rather than a one-off low-cost device, with implications for pricing, insurers and suppliers in India. - Localising Production: What Motorica’s Move into India Means for Market Entry
Motorica has started making its Indy Hand myoelectric prosthesis in Ghaziabad. For manufacturers weighing India, local production is a market-entry route, not a guarantee of access.
